The Fixed-dose Combination Drug for Secondary Cardiovascular Prevention project: Improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives
- 16 November 2011
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 162 (5), 811-817.e1
- https://doi.org/10.1016/j.ahj.2011.08.012
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The Polypill in the Prevention of Cardiovascular DiseasesCirculation, 2010
- Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countriesThe Lancet, 2009
- Prevalence, Predictors, and Outcomes of Primary Nonadherence After Acute Myocardial InfarctionCirculation, 2008
- The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countriesPublished by WHO Press ,2007
- Efficacy of Drug Therapy in the Secondary Prevention of Cardiovascular Disease and StrokeThe American Journal of Cardiology, 2007
- The Preventive Polypill — Much Promise, Insufficient EvidenceNew England Journal of Medicine, 2007
- Benefits, challenges, and registerability of the polypillEuropean Heart Journal, 2006
- Variations in Patients’ Adherence to Medical RecommendationsMedical Care, 2004
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986